Outcome or subgroup title,No. of studies,No. of participants,Statistical method,Effect size,comparison_name,comparison_id,effect_size,lower_ci,upper_ci,outcome_id,subgroup_id,outcome_name,subgroup_name
1 Proportion of participants achieving clear or almost clear skin (PASI 90 or 100 or PGA 0 or 1) Show forest plot,1,20,"Risk Ratio (M‐H, Random, 95% CI)","2.0 [0.68, 5.85]",Penicillin versus no treatment in guttate psoriasis,1,2.0,0.68,5.85,1,,Proportion of participants achieving clear or almost clear skin (PASI 90 or 100 or PGA 0 or 1),
1 Proportion of participants achieving PASI 75 or PGA 1 to 2 Show forest plot,1,50,"Risk Ratio (M‐H, Random, 95% CI)","25.06 [1.60, 393.59]",Oral azithromycin versus vitamin C in chronic plaque psoriasis,2,25.06,1.6,393.59,1,,Proportion of participants achieving PASI 75 or PGA 1 to 2,
1 Number of participants with adverse events or severe adverse events Show forest plot,1,29,"Risk Ratio (IV, Random, 95% CI)","2.81 [0.12, 63.83]",Tonsillectomy versus no intervention in chronic plaque psoriasis,3,2.81,0.12,63.83,1,,Number of participants with adverse events or severe adverse events,
2 Proportion of participants achieving clear or almost clear skin (PASI 90 or 100 or PGA 0 or 1) Show forest plot,1,29,"Risk Ratio (IV, Random, 95% CI)","2.81 [0.12, 63.83]",Tonsillectomy versus no intervention in chronic plaque psoriasis,3,2.81,0.12,63.83,2,,Proportion of participants achieving clear or almost clear skin (PASI 90 or 100 or PGA 0 or 1),
3 Proportion of participants achieving PASI 75 or PGA 1 to 2 Show forest plot,1,29,"Risk Ratio (IV, Random, 95% CI)","6.56 [0.37, 116.70]",Tonsillectomy versus no intervention in chronic plaque psoriasis,3,6.56,0.37,116.7,3,,Proportion of participants achieving PASI 75 or PGA 1 to 2,
